Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06527287 · ClinicalTrials.gov registry record · NA
Neurocognitive Ankle Training for Instability to Optimize Neuromusculoskeletal Outcomes (NATION)
A NA study, sponsored by Womack Army Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT06527287: Recruiting NA study, sponsored by Womack Army Medical Center.
NCT06527287 is a NA study that is actively recruiting participants, run by Womack Army Medical Center. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06527287, a NA study, is actively recruiting participants, sponsored by Womack Army Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of a novel ankle rehabilitation protocol on improving clinical and health outcomes in physically active individuals with chronic ankle instability (CAI). Our central hypothesis is NATION, a novel rehabilitation intervention that includes neurocognitive tasks, will improve overall health and function, and reduce lower extremity musculoskeletal injury in physically active individuals with CAI.
Primary Outcome
Ankle plantarflexion, dorsiflexion, inversion, and eversion peak isometric force will be assessed with a hand-held dynamometer
Interventions
- OTHER Neurocognitive Ankle Training for Instablity to Optimize Neuromusculoskeletal outcomes (NATION)
- OTHER Evidence-Based
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-10-13 |
| Est. Completion | 2027-06-14 |
| Phase | NA |
What NCT06527287 shows while recruiting
NCT06527287 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Neurocognitive Ankle Training for Instablity to Optimize Neuromusculoskeletal outcomes (NATION) is the first listed.
NCT06527287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06527287 about?
NCT06527287 is a clinical study titled "Neurocognitive Ankle Training for Instability to Optimize Neuromusculoskeletal Outcomes (NATION)". The purpose of this study is to examine the effectiveness of a novel ankle rehabilitation protocol on improving clinical and health outcomes in physically active individuals with chronic ankle instability (CAI). Our central hypothesis is NATION, a novel rehabilitation intervention that includes neur...
What is the current status of trial NCT06527287?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-10-13. Estimated completion is 2027-06-14.
What interventions are being tested in trial NCT06527287?
The interventions under investigation include: Neurocognitive Ankle Training for Instablity to Optimize Neuromusculoskeletal outcomes (NATION) (OTHER), Evidence-Based (OTHER).
Who is sponsoring clinical trial NCT06527287?
This trial is sponsored by Womack Army Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06527287's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI